Tuesday 14 July 2026

United Kingdom

GOQii launches UK Operations in partnership with Modality for enhanced patient care
01st September, 2023

GOQii launches UK Operations in partnership with Modality for enhanced patient care

GOQii Healthcare, a smart preventive healthcare company announced that it h...

Nemaura Medical Secures $6.5m in Non-Dilutive Funding
14th August, 2023

Nemaura Medical Secures $6.5m in Non-Dilutive Funding

Nemaura Medical, Inc. , a medical technology company focused on commerciali...

Day One Strategy to launch new healthcare division dedicated to AI-powered innovation and Digital Advisory Services
03rd August, 2023

Day One Strategy to launch new healthcare division dedicated to AI-powered innovation and Digital Advisory Services

Day One Strategy, the trailblazing strategy, data, and insights firm based ...

Lifebit Collaborates with Latin American Visionaries to Support Genomic Diversity
27th July, 2023

Lifebit Collaborates with Latin American Visionaries to Support Genomic Diversity

London-based precision medicine software provider Lifebit has agreed p...

OrganOx Secures £25M in Growth Round Led by Lauxera Capital
18th July, 2023

OrganOx Secures £25M in Growth Round Led by Lauxera Capital

OrganOx Ltd, a world-leading medical technology company committed to making...

LumiraDx Submits FDA 510(k) Application for COVID Ultra Test
03rd July, 2023

LumiraDx Submits FDA 510(k) Application for COVID Ultra Test

LumiraDx Limited, a leading innovator in diagnostic technologies, today ann...

Altis Labs Secures $6M in Seed Funding to Drive AI Platform for Clinical Trials
26th June, 2023

Altis Labs Secures $6M in Seed Funding to Drive AI Platform for Clinical Trials

Altis Labs, Inc., the computational imaging company accelerating clinical t...

UK Research and Innovation have awarded £34 million in funding for BioFAIR
20th June, 2023

UK Research and Innovation have awarded £34 million in funding for BioFAIR

UK has conceived BioFAIR, a new digital research infrastructure that enable...

Telesis Bio Announced as Featured Presenter at SynBioBeta 2023
24th May, 2023

Telesis Bio Announced as Featured Presenter at SynBioBeta 2023

Telesis Bio Inc., a leader in automated multi-omic and synthetic biology so...

NMD Pharma launches Phase I study of NMD1343 for safety and pharmacokinetics
23rd May, 2023

NMD Pharma launches Phase I study of NMD1343 for safety and pharmacokinetics

NMD Pharma A/S, a clinical-stage biotech company developing first-in-class,...

PharmEnable Secures $7.5M Funding, Led by MP Healthcare, for Novel Cancer and Neurological Disease Therapies
22nd May, 2023

PharmEnable Secures $7.5M Funding, Led by MP Healthcare, for Novel Cancer and Neurological Disease Therapies

PharmEnable, a drug discovery company focused on chemical novelty, diversit...

Alpha Tau Expands Alpha DaRT Treatment to Vulvar Cancer in Cambridge University Trial
18th May, 2023

Alpha Tau Expands Alpha DaRT Treatment to Vulvar Cancer in Cambridge University Trial

Alpha Tau Medical Ltd. has initiated a feasibility and safety study for the...